Literature DB >> 29364878

Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism.

Kairui Mao1, Antonio P Baptista1, Samira Tamoutounour2, Lenan Zhuang3, Nicolas Bouladoux2, Andrew J Martins4, Yuefeng Huang5, Michael Y Gerner6, Yasmine Belkaid2, Ronald N Germain1.   

Abstract

The mammalian gut is colonized by numerous microorganisms collectively termed the microbiota, which have a mutually beneficial relationship with their host. Normally, the gut microbiota matures during ontogeny to a state of balanced commensalism marked by the absence of adverse inflammation. Subsets of innate lymphoid cells (ILCs) and conventional T cells are considered to have redundant functions in containment and clearance of microbial pathogens, but how these two major lymphoid-cell populations each contribute to shaping the mature commensal microbiome and help to maintain tissue homeostasis has not been determined. Here we identify, using advanced multiplex quantitative imaging methods, an extensive and persistent phosphorylated-STAT3 signature in group 3 ILCs and intestinal epithelial cells that is induced by interleukin (IL)-23 and IL-22 in mice that lack CD4+ T cells. By contrast, in immune-competent mice, phosphorylated-STAT3 activation is induced only transiently by microbial colonization at weaning. This early signature is extinguished as CD4+ T cell immunity develops in response to the expanding commensal burden. Physiologically, the persistent IL-22 production from group 3 ILCs that occurs in the absence of adaptive CD4+ T-cell activity results in impaired host lipid metabolism by decreasing lipid transporter expression in the small bowel. These findings provide new insights into how innate and adaptive lymphocytes operate sequentially and in distinct ways during normal development to establish steady-state commensalism and tissue metabolic homeostasis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29364878     DOI: 10.1038/nature25437

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

Review 1.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.

Authors:  Harald Renz; Per Brandtzaeg; Mathias Hornef
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

2.  Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection.

Authors:  Xiaohuan Guo; Ju Qiu; Tony Tu; Xuanming Yang; Liufu Deng; Robert A Anders; Liang Zhou; Yang-Xin Fu
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

3.  Innate lymphoid cell function in the context of adaptive immunity.

Authors:  Jennifer K Bando; Marco Colonna
Journal:  Nat Immunol       Date:  2016-06-21       Impact factor: 25.606

4.  Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes.

Authors:  Michael Y Gerner; Wolfgang Kastenmuller; Ina Ifrim; Juraj Kabat; Ronald N Germain
Journal:  Immunity       Date:  2012-08-02       Impact factor: 31.745

5.  Conventional CD4+ T cells regulate IL-22-producing intestinal innate lymphoid cells.

Authors:  L L Korn; H L Thomas; H G Hubbeling; S P Spencer; R Sinha; H Ma Simkins; N H Salzman; F D Bushman; T M Laufer
Journal:  Mucosal Immunol       Date:  2014-01-22       Impact factor: 7.313

6.  Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence.

Authors:  Sales Ibiza; Bethania García-Cassani; Hélder Ribeiro; Tânia Carvalho; Luís Almeida; Rute Marques; Ana M Misic; Casey Bartow-McKenney; Denise M Larson; William J Pavan; Gérard Eberl; Elizabeth A Grice; Henrique Veiga-Fernandes
Journal:  Nature       Date:  2016-07-13       Impact factor: 49.962

Review 7.  Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets.

Authors:  Difeng Fang; Jinfang Zhu
Journal:  J Exp Med       Date:  2017-06-19       Impact factor: 14.307

Review 8.  STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?

Authors:  Paul M Nguyen; Tracy L Putoczki; Matthias Ernst
Journal:  J Interferon Cytokine Res       Date:  2015-03-11       Impact factor: 2.607

9.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583

10.  The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.

Authors:  Christoph S N Klose; Tanel Mahlakõiv; Jesper B Moeller; Lucille C Rankin; Anne-Laure Flamar; Hiroki Kabata; Laurel A Monticelli; Saya Moriyama; Gregory Garbès Putzel; Nikolai Rakhilin; Xiling Shen; Evi Kostenis; Gabriele M König; Takashi Senda; Dustin Carpenter; Donna L Farber; David Artis
Journal:  Nature       Date:  2017-09-06       Impact factor: 49.962

View more
  109 in total

1.  Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Authors:  Rabi Yacoub; Girish N Nadkarni; Daniel I McSkimming; Lee D Chaves; Sham Abyad; Mark A Bryniarski; Amanda M Honan; Shruthi A Thomas; Madan Gowda; John C He; Jaime Uribarri
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

2.  Mettl3 Deficiency Sustains Long-Chain Fatty Acid Absorption through Suppressing Traf6-Dependent Inflammation Response.

Authors:  Xin Zong; Jing Zhao; Hong Wang; Zeqing Lu; Fengqin Wang; Huahua Du; Yizhen Wang
Journal:  J Immunol       Date:  2018-12-19       Impact factor: 5.422

3.  NOD2 drives early IL-33-dependent expansion of group 2 innate lymphoid cells during Crohn's disease-like ileitis.

Authors:  Carlo De Salvo; Kristine-Ann Buela; Brecht Creyns; Daniele Corridoni; Nitish Rana; Hannah L Wargo; Chiara L Cominelli; Peter G Delaney; Alexander Rodriguez-Palacios; Fabio Cominelli; Séverine Vermeire; Theresa T Pizarro
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

4.  Fecal microbiota transplantation from patients with autoimmune encephalitis modulates Th17 response and relevant behaviors in mice.

Authors:  Hao Chen; Zhaoyu Chen; Liping Shen; Xiuhua Wu; Xueying Ma; Dengna Lin; Man Zhang; Xiaomeng Ma; Yingying Liu; Zhanhang Wang; Yuefeng Zhang; Zuying Kuang; Zhiwei Lu; Xuefei Li; Lili Ma; Xiuli Lin; Lei Si; Xiaohong Chen
Journal:  Cell Death Discov       Date:  2020-08-11

Review 5.  Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity.

Authors:  Marco Colonna
Journal:  Immunity       Date:  2018-06-19       Impact factor: 31.745

Review 6.  Innate Lymphoid Cells: Their Contributions to Gastrointestinal Tissue Homeostasis and HIV/SIV Disease Pathology.

Authors:  Joseph C Mudd; Jason M Brenchley
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

Review 7.  Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut.

Authors:  Wenqing Zhou; Gregory F Sonnenberg
Journal:  Trends Immunol       Date:  2020-07-06       Impact factor: 16.687

Review 8.  The interplay between innate lymphoid cells and T cells.

Authors:  Marie Cherrier; Gayetri Ramachandran; Rachel Golub
Journal:  Mucosal Immunol       Date:  2020-07-10       Impact factor: 7.313

Review 9.  Keeping time in group 3 innate lymphoid cells.

Authors:  Qianli Wang; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2020-08-05       Impact factor: 53.106

10.  An intact gut microbiome protects genetically predisposed mice against leukemia.

Authors:  Carolina Vicente-Dueñas; Stefan Janssen; Marina Oldenburg; Franziska Auer; Inés González-Herrero; Ana Casado-García; Marta Isidro-Hernández; Javier Raboso-Gallego; Philipp Westhoff; Aleksandra A Pandyra; Daniel Hein; Katharina L Gössling; Diego Alonso-López; Javier De Las Rivas; Sanil Bhatia; Francisco Javier García-Criado; María Begoña García-Cenador; Andreas P M Weber; Karl Köhrer; Julia Hauer; Ute Fischer; Isidro Sánchez-García; Arndt Borkhardt
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.